Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism-Reference-Cited by-同舟云学术

Adrenal venous sampling criteria for chemiluminescent enzyme immunoassay as a preferable alternative to radioimmunoassay in primary aldosteronism

Published:2024 Issue:5 Volume:71 Page:461-469
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Nakai Kazuki¹^ORCID,Tsurutani Yuya¹^ORCID,Irie Koki¹²,Teruyama Kyoko³,Suematsu Sachiko¹,Matsui Seishi⁴,Makita Kohzoh⁵,Saito Jun¹^ORCID,Omura Masao¹⁶^ORCID,Nishikawa Tetsuo¹⁷^ORCID

Affiliation:

1. Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Kanagawa 222-0036, Japan

2. Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo 113-8655, Japan

3. Product Planning Department, Fujirebio Inc., Tokyo 107-0052, Japan

4. Department of Radiology, Yokohama Rosai Hospital, Kanagawa 222-0036, Japan

5. Department of Radiology, Nerima Hikarigaoka Hospital, Tokyo 179-0072, Japan

6. Minato Mirai Medical Square, Kanagawa 220-0012, Japan

7. Nishikawa Clinic, Kanagawa 222-0033, Japan

Publisher

Japan Endocrine Society

Link

https://www.jstage.jst.go.jp/article/endocrj/71/5/71_EJ23-0695/_pdf

Reference12 articles.

1. 1 Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, et al. (2011) Guidelines for the diagnosis and treatment of primary aldosteronism—the Japan Endocrine Society 2009. Endocr J 58: 711–721.

2. 2 Nishikawa T, Omura M, Kawaguchi M, Takatsu A, Satoh F, et al. (2016) Calibration and evaluation of routine methods by serum certified reference material for aldosterone measurement in blood. Endocr J 63: 1065–1080.

3. 3 Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, et al. (2022) Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J 69: 327–359.

4. 4 Nishikawa T, Satoh F, Takashi Y, Yanase T, Itoh H, et al. (2022) Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood. Endocr J 69: 45–54.

5. 5 Reincke M, Bancos I, Mulatero P, Scholl UI, Stowasser M, et al. (2021) Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol 9: 876–892.